GIGA - Université de Liège

What GIGA - Université de Liège does

GIGA is the Interdisciplinary Center for Biomedical Research of the University of Liège (ULiège), a public academic research institute established in 2007 and physically co-located within the University Hospital (CHU) on the Sart-Tilman campus in Belgium. The institute organizes its work around five thematic research units — Cancer, Neurosciences, Immunobiology, Metabolism & Cardiovascular Biology, and Molecular & Computational Biology — and operates ten technology platforms covering genomics, cell and in vivo imaging, flow cytometry, viral vectors and gene editing, immunohistology, proteomics, bioinformatics, animal facilities (mouse and zebrafish), and the newer HIPS Human Imaging Platform. These platforms serve both internal academic researchers and external industry/biotech clients, providing sequencing, microscopy, proteomics, CRISPR-based gene editing, and computational biology services alongside expert consultation and training.

GIGA's operating model is primarily grant-funded rather than commercially driven. The institute reported €32.3 million in annual funding for 2022, sourced from the Walloon Region (21.8%), Fédération Wallonie-Bruxelles (21.8%), ULiège (15.9%), EU programs such as ERC and Horizon 2020 (13%), donations and contracts (12%), FEDER (2.2%), and the Belgian federal government (2%). Output metrics include 608 research staff of 41 nationalities, 479 scientific publications in 2022, 41 PhD theses defended, and 490 active research projects with 55 international partner countries. The institute also maintains a labhotel for hosting spin-offs and start-ups, supporting research valorization, and collaborates closely with CHU de Liège for clinical translation.

The go-to-market is community-led: GIGA engages the scientific community through publications, conference participation, technology platform service offerings, and academic-industry research collaborations. Customer segments split horizontally between academic researchers (primary) and industry/biotech companies (secondary), with co-located CHU de Liège as a strategic clinical partner. Pricing is not publicly disclosed; platform services are provided to external users on a cost-recovery or contractual basis. Leadership includes Director Michel Georges, Directrice Générale Brigitte Malgrange, Directeur Scientifique Laurent Nguyen, and dedicated heads for each research unit, including Steven Laureys (GIGA-Consciousness), Julie Bakker (GIGA-Neurosciences), and Patrizio Lancellotti (GIGA-Cardiovascular).

Name

GIGA - Université de Liège

Legal name

GIGA - Université de Liège

Website

https://giga.uliege.be

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

51–100 employees

Short description

GIGA is the public interdisciplinary biomedical research center of the University of Liège, Belgium, operating ten technology platforms and five thematic research units (cancer, neuroscience, immunology, cardiovascular, molecular biology) to serve academic researchers, biotech industry, and clinical collaborators.

Ownership category

akta.pro rank

Product category

Biomedical Research Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Bioinformatics, Multi-Omics Data Analysis & Interpretation Services (HLAGANAI)

akta.pro secondary industries

Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D) (HLAGAJAC), Transcriptomics & Gene Expression Profiling Services (HLAGANAE), Cell-Based & Potency Assays (Bioassays) (HLAGADAH)

Keywords

• Biomedical research
• Technology platforms
• Genomics services
• Proteomics analysis
• Academic research center

Headquarters

HQ city

Liège

HQ country

Belgium

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations

Revenue model

1. Public Research Funding: GIGA is funded primarily through public sources including federal government (2%), Walloon Region (21.8%), Wallonie/Bxl Federation (21.8%), ULiège (15.9%), EU funding (13%), and FEDER/ERDF (2.2%)

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

GIGA is an interdisciplinary biomedical research center at the University of Liège that operates nine technology platforms (genomics, cell imaging, flow cytometry, in vivo imaging, viral vectors and gene editing, immunohistology, proteomics, bioinformatics, and animal facilities) providing research services to academic and industry researchers. It also runs five thematic research units covering cancer, neurosciences, immunobiology, metabolism and cardiovascular biology, and molecular and computational biology, while hosting spin-offs and start-ups through its labhotel facility.

Product overview

GIGA is an interdisciplinary biomedical research center at the University of Liège providing research services through a portfolio of nine technology platforms (Genomics, Cell Imaging, Flow Cytometry, In Vivo Imaging, Viral Vectors and Gene Editing, Immunohistology, Proteomics, Bioinformatics, Animal Facilities) and five thematic research units (Cancer, Neurosciences, Immunobiology, Metabolism & Cardiovascular Biology, Molecular & Computational Biology). The center offers services to academic researchers and industry, with state-of-the-art technology, expert-led analyses, and cost-effective local services. GIGA also hosts a labhotel for spin-offs and start-ups and promotes research valorization.

Differentiator

Problem solved

Functional benefit

Products and services

• Genomics Platform

Quantifiable outcome

• 479 scientific publications in 2022
• +2 more outcomes

Named customers3 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature9 records

Partnerships

Two partnerships are on record, tiered core and major.

• CHU de Liège (University Hospital)coreStrategic or Co-development PartnerIntegrated partnership within the University Hospital site, enabling clinical research translation and collaborative biomedical research between GIGA and CHU clinical departments
• Fondation Léon FredericqmajorStrategic or Co-development PartnerFoundation of Public Utility supporting medical and biomedical research at Liège, supporting young researchers with clinical research fellowships, travel grants, and operating/equipment credits

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• European Molecular Biology Laboratory (EMBL): Intergovernmental European research organization operating multi-site molecular biology core facilities (genomics, imaging, proteomics, bioinformatics). Comparable in delivering technology platforms to academic and industry researchers across Europe.
• VIB (Vlaams Instituut voor Biotechnologie): Belgian life sciences research institute operating technology platforms and core facilities supporting biomedical research with a similar public-funded, multi-site academic model. Most structurally comparable peer because of shared Belgian university-hospital embedded biotech research mission and industry valorization.
• Karolinska Institutet: Swedish medical university with strong biomedical research infrastructure, core facilities, and clinical translation via affiliated hospital. Comparable in academic biomedical research scale and platform-driven services.
• Helmholtz Centre for Infection Research (HZI): German publicly funded research center with immunology, infection biology and platform-based research. Comparable in public funding mix, platform services, and translational research mission.
• Francis Crick Institute: UK biomedical discovery institute with technology platforms and translational research. Comparable in operating as a multi-platform research center embedded within a larger hospital/research ecosystem.
• CNRS (Centre national de la recherche scientifique) - Biology: French national scientific research center with extensive life sciences laboratories and technology platforms. Comparable in public funding structure, multi-platform research delivery, and academic valorization model.
• Institut Pasteur: French non-profit biomedical research institute combining basic research, technology platforms (genomics, imaging, cytometry), and clinical translation. Comparable in mission, technology platform portfolio, and integrated research-hospital model.
• Max Planck Institutes: German publicly funded research organization with institutes running advanced biomedical technology platforms and core facilities. Comparable in scale, public funding model, and cross-disciplinary research output.
• Wellcome Sanger Institute: UK genomics and bioinformatics research center running large-scale sequencing, multi-omics, and data platforms. Comparable for its genomics platform and bioinformatics services similar to GIGA's platforms.

Broad incumbents

• Broad Institute of MIT and Harvard: Large US biomedical/genomics research institute with core platforms in genomics, proteomics, and imaging. Comparable in delivering multi-omics and computational biology platform services to a broad research community, though at significantly larger scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/GIGA_ULiege
• YouTubeyoutube.com/channel/UCzQhY0U5a2w0a9Z5cZ5Z5Z5
• Facebookfacebook.com/GIGAresearch
• Instagraminstagram.com/giga_uliege
• LinkedInlinkedin.com/company/giga-universit%C3%A9-de-li%C3%A8ge

Revenue estimate

Valuation estimate

Number of profiles

Profiles14 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about GIGA - Université de Liège